BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 239343)

  • 21. Sphingomyelinases in human tissues. III. Expression of Niemann-Pick disease in cultured skin fibroblasts.
    Callahan JW; Khalil M
    Pediatr Res; 1975 Dec; 9(12):914-8. PubMed ID: 172849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic hydrolysis of sphingomyelin liposomes by normal tissues and tissues from patients with Niemann-Pick disease.
    Poulos A; Shankaran P; Jones CS; Callahan JW
    Biochim Biophys Acta; 1983 May; 751(3):428-31. PubMed ID: 6303435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzymatic assay for quantifying sphingomyelin in tissues and plasma from humans and mice with Niemann-Pick disease.
    He X; Chen F; Gatt S; Schuchman EH
    Anal Biochem; 2001 Jun; 293(2):204-11. PubMed ID: 11399033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on sphingomyelinase activity in cultured cells and leucocytes.
    Besley GT
    J Inherit Metab Dis; 1978; 1(1):29-33. PubMed ID: 229341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of Niemann-Pick disease using a simple and sensitive fluorimetric assay of sphingomyelinase activity.
    Besley GT
    Clin Chim Acta; 1978 Dec; 90(3):269-78. PubMed ID: 31994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ultrastructural study of the liver in Niemann-Pick disease type C].
    Chamlian A; Benkoël L; Payan MJ; Minko D; Xerri L; Choux R; Nouhou H
    Ann Pathol; 1989; 9(2):132-6. PubMed ID: 2735974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letters: A simple sphingomyelinase determination for Niemann-Pick disease: differential diagnosis of types A, B and C.
    Harzer K; Benz HU
    J Neurochem; 1973 Oct; 21(4):999-1001. PubMed ID: 4356842
    [No Abstract]   [Full Text] [Related]  

  • 28. The diagnosis of type A and type B Niemann Pick disease and detection of carriers using leukocytes and a chromogenic analogue of sphingomyelin.
    Gal AE; Brady RO; Barranger JA; Pentchev PG
    Clin Chim Acta; 1980 May; 104(1):129-32. PubMed ID: 7389124
    [No Abstract]   [Full Text] [Related]  

  • 29. [Type B Niemann-Pick disease. Clinical aspects].
    Ricca V; Landi M; Calì M; Aimar A; Lala R; Corrias A; Javarone A
    Minerva Pediatr; 1986 Jun; 38(11-12):477-81. PubMed ID: 3736526
    [No Abstract]   [Full Text] [Related]  

  • 30. Prenatal diagnosis of Niemann-Pick disease type A using chromogenic substrate.
    Patrick AD; Young E; Kleijer WJ; Niermeijer MF
    Lancet; 1977 Jul; 2(8029):144. PubMed ID: 69227
    [No Abstract]   [Full Text] [Related]  

  • 31. Sphingomyelinase and nonspecific phosphodiesterase activities in Epstein-Barr virus-transformed lymphoid cell lines from Niemann-Pick disease A, B and C.
    Levade T; Salvayre R; Lenoir G; Douste-Blazy L
    Biochim Biophys Acta; 1984 Apr; 793(2):321-4. PubMed ID: 6324871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative evaluation of sphingomyelin and glucosylceramide using matrix-assisted laser desorption ionization time-of-flight mass spectrometry with sphingosylphosphorylcholine as an internal standard. Practical application to tissues from patients with Niemann-Pick disease types A and C, and Gaucher disease.
    Fujiwaki T; Tasaka M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):170-6. PubMed ID: 18502707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New tools for the study of Niemann-Pick disease: analogues of natural substrate and Epstein-Barr virus-transformed lymphoid cell lines.
    Levade T; Salvayre R; Bes JC; Nezri M; Douste-Blazy L
    Pediatr Res; 1985 Jan; 19(1):153-7. PubMed ID: 2982124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on sphingomyelinase and beta-glucosidase activities in Niemann-Pick disease variants. Phosphodiesterase activities measured with natural and artificial substrates.
    Besley GT; Moss SE
    Biochim Biophys Acta; 1983 Jun; 752(1):54-64. PubMed ID: 6303436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sphingomyelinase activity in a patient with Niemann-Pick disease].
    Sengers RC; Wevers RA; van Haelst UJ; Smeets HL
    Tijdschr Kindergeneeskd; 1989 Apr; 57(2):70-3. PubMed ID: 2545015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal diagnosis of Niemann-Pick diseases types A, B and C.
    Vanier MT
    Prenat Diagn; 2002 Jul; 22(7):630-2. PubMed ID: 12124701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay of beta-glucosidase and sphingomyelinase for identification of patients and carriers of Gaucher's and Niemann-Pick diseases.
    Wenger DA
    Adv Exp Med Biol; 1978; 101():707-17. PubMed ID: 208369
    [No Abstract]   [Full Text] [Related]  

  • 38. A practical chromogenic procedure for the diagnosis of Krabbe's disease.
    Gal AE; Brady RO; Pentchev PG; Furbish FS; Suzuki K; Tanaka H; Schneider EL
    Clin Chim Acta; 1977 May; 77(1):53-9. PubMed ID: 17489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Niemann-Pick disease with sphingomyelinase deficiency in two brothers with mental retardation.
    Sogawa H; Horino K; Nakamura F; Kudoh T; Oyanagi K; Yamanouchi T; Minami R; Nakao T; Watanabe A; Matsuura Y
    Eur J Pediatr; 1978 Jul; 128(4):235-40. PubMed ID: 208852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new fluorimetric enzyme assay for the diagnosis of Niemann-Pick A/B, with specificity of natural sphingomyelinase substrate.
    van Diggelen OP; Voznyi YV; Keulemans JL; Schoonderwoerd K; Ledvinova J; Mengel E; Zschiesche M; Santer R; Harzer K
    J Inherit Metab Dis; 2005; 28(5):733-41. PubMed ID: 16151905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.